Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
Álvaro Sánchez-Martínez(University of Cambridge), Anthony H.V. Schapira(National Hospital for Neurology and Neurosurgery), Kai‐Yin Chau(National Hospital for Neurology and Neurosurgery), Michelle Beavan(University College London), Matthew E. Gegg(National Hospital for Neurology and Neurosurgery), Alexander J. Whitworth(University of Cambridge)
Cited by 159
Related Papers
Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy
|Human Molecular Genetics|2010|896
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
Mitochondrial defect in Huntington's disease caudate nucleus
|Annals of Neurology|1996|738
Priorities in Parkinson's disease research
|Nature Reviews Drug Discovery|2011|430
Basal mitophagy is widespread in <i>Drosophila</i> but minimally affected by loss of Pink1 or parkin
|The Journal of Cell Biology|2018|364